Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease

Clinical and Vaccine Immunology

Volumn 15, Issue 12, 2008, Pages 1796-1804

  Ledue, Thomas B ^a   Collins, Marilyn F ^a   Young, John ^b   Schriefer, Martin E ^b  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LYME DISEASE VACCINE; RHEUMATOID FACTOR; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VLSE ANTIGEN;

ARTICLE; AUTOIMMUNE DISEASE; BACTERIUM DETECTION; BLOOD DONOR; BORRELIA BURGDORFERI; CHEMILUMINESCENCE IMMUNOASSAY; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LYME DISEASE; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPIROCHETE INFECTION; VIRUS INFECTION; WESTERN BLOTTING;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI; CHEMILUMINESCENT MEASUREMENTS; FEMALE; HUMANS; IMMUNOASSAY; LIPOPROTEINS; LYME DISEASE; LYME DISEASE VACCINES; MALE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 57349193535     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00195-08     Document Type: Article

References (65)

1. Aguero-Rosenfeld, M. E., J. Nowakowski, S. Bittker, D. Cooper, R. B. Nadelman, and G. P. Wormser. 1996. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J. Clin. Microbiol. 34:1-9.
2. Aguero-Rosenfeld, M. E., G. Wang, I. Schwartz, and G. P. Wormser. 2005. Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev. 18:484-509.
3. Akin, E., G. L. McHugh, R. A. Flavell, E. Fikrig, and A. C. Steere. 1999. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect. Immun. 67:173-181.
4. American College of Physicians. 1997. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Ann. Intern. Med. 127:1106-1108.
5. Bacon, R. M., B. J. Biggerstaff, M. E. Schriefer, R. D. Gilmore, Jr., M. T. Philipp, A. C. Steere, G. P. Wormser, A. R. Marques, and B. J. Johnson. 2003. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J. Infect. Dis. 187:1187-1199.
6. Bakken, L. L., S. M. Callister, P. J. Wand, and R. F. Schell. 1997. Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists Proficiency Testing Program. J. Clin. Microbiol. 35:537-543.
7. Bakken, L. L., K. L. Case, S. M. Callister, N. J. Bourdeau, and R. F. Schell. 1992. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA 268:891-895.
8. Barbour, A. G. 1990. Antigenic variation of a relapsing fever Borrelia species. Annu. Rev. Microbiol. 44:155-171.
9. Bergstrom, S., A. Sjostedt, L. Dotevall, B. Kaijser, B. Ekstrand-Hammarstrom, C. Wallberg, G. Skogman, and A. G. Barbour. 1991. Diagnosis of Lyme borreliosis by an enzyme immunoassay detecting immunoglobulin G reactive to purified Borrelia burgdorferi cell components. Eur. J. Clin. Microbiol. Infect. Dis. 10:422-427.
10. CDC. 1997. Lyme disease - United States, 1996. MMWR Morb. Mortal. Wkly. Rep. 46:531-535.
11. CDC. 1995. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb. Mortal. Wkly. Rep. 44:590-591.
12. CLSI. 2005. User verification of performance for precision and trueness. Approved guideline EP15-A2, 2nd ed. CLSI, Wayne, PA.
13. DePietropaolo, D. L., J. H. Powers, J. M. Gill, and A. J. Foy. 2005. Diagnosis of Lyme disease. Am. Fam. Physician 72:297-304.
14. Eicken, C., V. Sharma, T. Klabunde, M. B. Lawrenz, J. M. Hardham, S. J. Norris, and J. C. Sacchettini. 2002. Crystal structure of Lyme disease variable surface antigen VlsE of Borrelia burgdorferi. J. Biol. Chem. 277:21691-21696.
15. Embers, M. E., G. P. Wormser, I. Schwartz, D. S. Martin, and M. T. Philipp. 2007. Borrelia burgdorferi spirochetes that harbor only a portion of the lp28-1 plasmid elicit antibody responses detectable with the C6 test for Lyme disease. Clin. Vaccine Immunol. 14:90-93.
16. Fawcett, P. T., C. D. Rose, and V. Maduskuie. 2004. Long-term effects of immunization with recombinant lipoprotein outer surface protein A on serologic test for Lyme disease. Clin. Diagn. Lab. Immunol. 11:808-810.
17. Feder, H. M., Jr., M. A. Gerber, S. W. Luger, and R. W. Ryan. 1992. Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin. Infect. Dis. 15:788-793.
18. Gassmann, G. S., E. Jacobs, R. Deutzmann, and U. B. Gobel. 1991. Analysis of the Borrelia burgdorferi GeHo fla gene and antigenic characterization of its gene product. J. Bacteriol. 173:1452-1459.
19. Gern, L., C. M. Hu, E. Kocianova, V. Vyrostekova, and J. Rehacek. 1999. Genetic diversity of Borrelia burgdorferi sensu lato isolates obtained from Ixodes ricinus ticks collected in Slovakia. Eur. J. Epidemiol. 15:665-669.
20. Goettner, G., U. Schulte-Spechtel, R. Hillermann, G. Liegl, B. Wilske, and V. Fingerle. 2005. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues. J. Clin. Microbiol. 43:3602-3609.
21. Hansen, K., J. M. Bangsborg, H. Fjordvang, N. S. Pedersen, and P. Hindersson. 1988. Immunochemical characterization of and isolation of the gene for a Borrelia burgdorferi immunodominant 60-kilodalton antigen common to a wide range of bacteria. Infect. Immun. 56:2047-2053.
22. Hansen, K., K. Pii, and A. M. Lebech. 1991. Improved immunoglobulin M serodiagnosis in Lyme borreliosis by using a -capture enzyme-linked immunosorbent assay with biotinylated Borrelia burgdorferi flagella. J. Clin. Microbiol. 29:166-173.
23. Heikkila, T., I. Seppala, H. Saxen, J. Panelius, H. Yrjanainen, and P. Lahdenne. 2002. Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A. J. Clin. Microbiol. 40:453-460.
24. Jouda, F., M. Crippa, J. L. Perret, and L. Gern. 2003. Distribution and prevalence of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks of canton Ticino (Switzerland). Eur. J. Epidemiol. 18:907-912.
25. Kaplan, I. V., and S. S. Levinson. 1999. When is a heterophile antibody not a heterophile antibody? When it is an antibody against a specific immunogen. Clin. Chem. 45:616-618.
26. Karlsson, M., I. Mollegard, G. Stiernstedt, and B. Wretlind. 1989. Comparison of Western blot and enzyme-linked immunosorbent assay for diagnosis of Lyme borreliosis. Eur. J. Clin. Microbiol. Infect. Dis. 8:871-877.
27. Koide, S., X. Yang, X. Huang, J. J. Dunn, and B. J. Luft. 2005. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA. J. Mol. Biol. 350:290-299.
28. Lawrenz, M. B., J. M. Hardham, R. T. Owens, J. Nowakowski, A. C. Steere, G. P. Wormser, and S. J. Norris. 1999. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J. Clin. Microbiol. 37:3997-4004.
29. Ledue, T. B., M. F. Collins, and W. Y. Craig. 1996. New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol. J. Clin. Microbiol. 34:2343-2350.
30. Liang, F. T., A. L. Alvarez, Y. Gu, J. M. Nowling, R. Ramamoorthy, and M. T. Philipp. 1999. An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi. J. Immunol. 163:5566-5573.
31. Liang, F. T., A. C. Steere, A. R. Marques, B. J. Johnson, J. N. Miller, and M. T. Philipp. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J. Clin. Microbiol. 37:3990-3996.
32. Luft, B. J., P. D. Gorevic, W. Jiang, P. Munoz, and R. J. Dattwyler. 1991. Immunologic and structural characterization of the dominant 66- to 73-kDa antigens of Borrelia burgdorferi. J. Immunol. 146:2776-2782.
33. Ma, B., B. Christen, D. Leung, and C. Vigo-Pelfrey. 1992. Serodiagnosis of Lyme borreliosis by Western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi. J. Clin. Microbiol. 30:370-376.
34. Magnarelli, L. A., J. F. Anderson, and R. C. Johnson. 1987. Cross-reactivity in serological tests for Lyme disease and other spirochetal infections. J. Infect. Dis. 156:183-188.
35. Magnarelli, L. A., E. Fikrig, S. J. Padula, J. F. Anderson, and R. A. Flavell. 1996. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis. J. Clin. Microbiol. 34:237-240.
36. Magnarelli, L. A., J. W. Ijdo, S. J. Padula, R. A. Flavell, and E. Fikrig. 2000. Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens. J. Clin. Microbiol. 38:1735-1739.
37. Magnarelli, L. A., J. M. Meegan, J. F. Anderson, and W. A. Chappell. 1984. Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease. J. Clin. Microbiol. 20:181-184.
38. Marangoni, A., V. Sambri, S. Accardo, F. Cavrini, V. Mondardini, A. Moroni, E. Storni, and R. Cevenini. 2006. A decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease. Clin. Vaccine Immunol. 13:525-529.
39. Marangoni, A., M. Sparacino, V. Mondardini, F. Cavrini, E. Storni, M. Donati, R. Cevenini, and V. Sambri. 2005. Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy. New Microbiol. 28:37-43.
40. Marques, A. R., D. S. Martin, and M. T. Philipp. 2002. Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine. J. Clin. Microbiol. 40:2591-2593.
41. Massarotti, E. M., S. W. Luger, D. W. Rahn, R. P. Messner, J. B. Wong, R. C. Johnson, and A. C. Steere. 1992. Treatment of early Lyme disease. Am. J. Med. 92:396-403.
42. McDowell, J. V., S. Y. Sung, L. T. Hu, and R. T. Marconi. 2002. Evidence that the variable regions of the central domain of VlsE are antigenic during infection with Lyme disease spirochetes. Infect. Immun. 70:4196-4203.
43. Mogilyansky, E., C. C. Loa, M. E. Adelson, E. Mordechai, and R. C. Tilton. 2004. Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease. Clin. Diagn. Lab. Immunol. 11:924-929.
44. Molloy, P. J., D. H. Persing, and V. P. Berardi. 2001. False-positive results of PCR testing for Lyme disease. Clin. Infect. Dis. 33:412-413.
45. Nadelman, R. B., and G. P. Wormser. 1998. Lyme borreliosis. Lancet 352:557-565.
46. Peltomaa, M., G. McHugh, and A. C. Steere. 2003. Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J. Infect. Dis. 187:1178-1186.
47. Philipp, M. T., L. C. Bowers, P. T. Fawcett, M. B. Jacobs, F. T. Liang, A. R. Marques, P. D. Mitchell, J. E. Purcell, M. S. Ratterree, and R. K. Straubinger. 2001. Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J. Infect. Dis. 184:870-878.
48. Philipp, M. T., G. P. Wormser, A. R. Marques, S. Bittker, D. S. Martin, J. Nowakowski, and L. G. Dally. 2005. A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme borreliosis. Clin. Diagn. Lab. Immunol. 12:1069-1074.
49. Rath, P. M., F. J. Fehrenbach, G. Rogler, H. D. Pohle, and A. Schonberg. 1992. Relapsing fever and its serological discrimination from Lyme borreliosis. Infection 20:283-286.
50. Rauer, S., N. Spohn, C. Rasiah, U. Neubert, and A. Vogt. 1998. Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 36:857-861.
51. Reed, K. D. 2002. Laboratory testing for Lyme disease: possibilities and practicalities. J. Clin. Microbiol. 40:319-324.
52. Sayahtaheri-Altaie, S., F. A. Meier, and H. P. Dalton. 1993. Identification of species-specific, non-cross-reactive proteins of Borrelia burgdorferi. Diagn. Microbiol. Infect. Dis. 16:43-51.
53. Smith, R. P. 2005. Current diagnosis and treatment of Lyme disease. Compr. Ther. 31:284-290.
54. Steere, A. C. 2001. Lyme disease. N. Engl. J. Med. 345:115-125.
55. Steere, A. C., J. Coburn, and L. Glickstein. 2004. The emergence of Lyme disease. J. Clin. Investig. 113:1093-1101.
56. Steere, A. C., R. L. Grodzicki, A. N. Kornblatt, J. E. Craft, A. G. Barbour, W. Burgdorfer, G. P. Schmid, E. Johnson, and S. E. Malawista. 1983. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 308:733-740.
57. Steere, A. C., E. Taylor, G. L. McHugh, and E. L. Logigian. 1993. The overdiagnosis of Lyme disease. JAMA 269:1812-1816.
58. Strle, F., and M. Stantic-Pavlinic. 1996. Lyme disease in Europe. N. Engl. J. Med. 334:803.
59. Takada, N., T. Masuzawa, F. Ishiguro, H. Fujita, M. Kudeken, H. Mitani, M. Fukunaga, K. Tsuchiya, Y. Yano, and X. H. Ma. 2001. Lyme disease Borrelia spp. in ticks and rodents from northwestern China. Appl. Environ. Microbiol. 67:5161-5165.
60. Trevejo, R. T., P. J. Krause, M. E. Schriefer, and D. T. Dennis. 2001. Evaluation of a two-test serodiagnostic method for community assessment of Lyme disease in an endemic area. Am. J. Trop. Med. Hyg. 65:563-566.
61. Tugwell, P., D. T. Dennis, A. Weinstein, G. Wells, B. Shea, G. Nichol, R. Hayward, R. Lightfoot, P. Baker, and A. C. Steere. 1997. Laboratory evaluation in the diagnosis of Lyme disease. Ann. Intern. Med. 127:1109-1123.
62. van Dam, A. P., H. Kuiper, K. Vos, A. Widjojokusumo, B. M. de Jongh, L. Spanjaard, A. C. Ramselaar, M. D. Kramer, and J. Dankert. 1993. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin. Infect. Dis. 17:708-717.
63. Wang, G., A. P. van Dam, I. Schwartz, and J. Dankert. 1999. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin. Microbiol. Rev. 12:633-653.
64. Wilske, B., G. Schierz, V. Preac-Mursic, K. Weber, H. W. Pfister, and K. Einhaupl. 1984. Serological diagnosis of erythema migrans disease and related disorders. Infection 12:331-337.
65. Zhang, Z. F., K. L. Wan, and J. S. Zhang. 1997. Studies on epidemiology and etiology of Lyme disease in China. Zhonghua Liu Xing Bing Xue Za Zhi. 18:8-11. [In Chinese.]